While Merck announced it was spending a few hundred million on an early-stage biotech this morning, we also see reports that it is shuttering an R&D site in Riom in the heart of France.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,